The estimated Net Worth of David S.Rbi Private Investm... is at least $149 Thousand dollars as of 27 June 2018. David Investm owns over 12,561 units of Rockwell Medical Inc stock worth over $148,621 and over the last 8 years David sold RMTI stock worth over $235.
David has made over 4 trades of the Rockwell Medical Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently David bought 12,561 units of RMTI stock worth $56,525 on 27 June 2018.
The largest trade David's ever made was buying 37,210 units of Rockwell Medical Inc stock on 21 March 2017 worth over $217,306. On average, David trades about 12,603 units every 116 days since 2017. As of 27 June 2018 David still owns at least 36,249 units of Rockwell Medical Inc stock.
You can see the complete history of David Investm stock trades at the bottom of the page.
Over the last 21 years, insiders at Rockwell Medical Inc have traded over $3,082,721 worth of Rockwell Medical Inc stock and bought 689,891 units worth $3,959,861 . The most active insiders traders include Robert L Chioini, David S.Rbi Private Investm..., and Thomas E Klema. On average, Rockwell Medical Inc executives and independent directors trade stock every 45 days with the average trade being worth of $170,433. The most recent stock trade was executed by David S.Rbi Private Investm... on 21 December 2020, trading 42,450 units of RMTI stock currently worth $43,724.
rockwell medical is a fully-integrated biopharmaceutical company targeting end-stage renal disease (esrd) and chronic kidney disease (ckd) with innovative products and services for the treatment of iron replacement, secondary hyperparathyroidism and hemodialysis. rockwell’s new innovative therapy triferic is the only fda approved drug indicated to replace iron and maintain hemoglobin in hemodialysis patients suffering from anemia. via dialysate during each dialysis treatment, triferic replaces the 5-7 mg iron loss that occurs in all patients, maintaining their iron balance. unlike iv iron products, triferic binds iron immediately and completely to transferrin (carrier of iron in the body) upon entering the blood and is then transported directly to the bone marrow to be incorporated into hemoglobin, with no increase in ferritin (stored iron and inflammation) and no anaphylaxis, addressing a significant unmet need in overcoming functional iron deficiency (fid) in esrd patients. visit www
Rockwell Medical Inc executives and other stock owners filed with the SEC include: